tiprankstipranks
Advertisement
Advertisement
AI-Enabled Target Discovery Highlights PRDX5 Opportunity in Mesothelioma
PremiumPrivate CompaniesAI-Enabled Target Discovery Highlights PRDX5 Opportunity in Mesothelioma
8d ago
AI-Driven Discovery Highlights PRDX5 as Potential Target in Mesothelioma Research
Premium
Private Companies
AI-Driven Discovery Highlights PRDX5 as Potential Target in Mesothelioma Research
8d ago
OWKIN Deepens U.K. Data Network and Sharpens AI Biology Strategy Amid Sector Funding Shifts
Premium
Private Companies
OWKIN Deepens U.K. Data Network and Sharpens AI Biology Strategy Amid Sector Funding Shifts
10d ago
AI-Driven Oncology Target Discovery Approach Highlighted by OWKIN
PremiumPrivate CompaniesAI-Driven Oncology Target Discovery Approach Highlighted by OWKIN
14d ago
OWKIN Emphasizes Novel Oncology Target Discovery With AI Scientist K Pro
Premium
Private Companies
OWKIN Emphasizes Novel Oncology Target Discovery With AI Scientist K Pro
14d ago
OWKIN – Weekly Recap
Premium
Private Companies
OWKIN – Weekly Recap
17d ago
OWKIN – Weekly Recap
PremiumPrivate CompaniesOWKIN – Weekly Recap
24d ago
OWKIN Positions AI Platform to Capitalize on FDA’s Move Toward AI-Enabled Clinical Trials
Premium
Private Companies
OWKIN Positions AI Platform to Capitalize on FDA’s Move Toward AI-Enabled Clinical Trials
24d ago
OWKIN Highlights AI Platform Aimed at Accelerating Clinical Trial Timelines
Premium
Private Companies
OWKIN Highlights AI Platform Aimed at Accelerating Clinical Trial Timelines
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100